Stryker Corporation (NYSE:SYK) Receives “Buy” Rating from Piper Jaffray Companies

Piper Jaffray Companies restated their buy rating on shares of Stryker Corporation (NYSE:SYK) in a research note issued to investors on Friday, October 27th. The firm currently has a $156.00 price target on the medical technology company’s stock.

A number of other research analysts have also recently weighed in on SYK. Cantor Fitzgerald assumed coverage on shares of Stryker Corporation in a research note on Thursday, June 29th. They set a neutral rating and a $153.00 target price on the stock. Jefferies Group LLC reiterated a hold rating and set a $132.00 price objective on shares of Stryker Corporation in a research note on Friday, June 30th. Morgan Stanley reissued an overweight rating and set a $160.00 target price (up previously from $155.00) on shares of Stryker Corporation in a research report on Monday, July 10th. BMO Capital Markets reissued a hold rating and set a $140.00 target price on shares of Stryker Corporation in a research report on Tuesday, July 11th. Finally, Zacks Investment Research raised shares of Stryker Corporation from a hold rating to a buy rating and set a $163.00 price target for the company in a report on Monday, July 17th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have issued a buy rating to the company. Stryker Corporation presently has a consensus rating of Hold and a consensus target price of $151.52.

Stryker Corporation (SYK) traded up $1.27 on Friday, hitting $155.75. The stock had a trading volume of 910,400 shares, compared to its average volume of 1,182,308. Stryker Corporation has a 52 week low of $106.48 and a 52 week high of $160.62. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. The firm has a market capitalization of $57,812.22, a PE ratio of 24.48, a price-to-earnings-growth ratio of 2.43 and a beta of 0.79.

Stryker Corporation (NYSE:SYK) last posted its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.50 by $0.02. Stryker Corporation had a return on equity of 24.11% and a net margin of 14.67%. The firm had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.97 billion. During the same quarter in the prior year, the business posted $1.39 earnings per share. The business’s quarterly revenue was up 6.1% on a year-over-year basis. analysts forecast that Stryker Corporation will post 6.47 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Stryker Corporation (NYSE:SYK) Receives “Buy” Rating from Piper Jaffray Companies” was published by Week Herald and is the property of of Week Herald. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://weekherald.com/2017/11/14/piper-jaffray-companies-reaffirms-buy-rating-for-stryker-corporation-syk.html.

In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the transaction, the insider now directly owns 83,207 shares in the company, valued at $12,925,375.38. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 7.40% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently modified their holdings of the company. Coldstream Capital Management Inc. grew its position in Stryker Corporation by 3.7% during the 2nd quarter. Coldstream Capital Management Inc. now owns 17,445 shares of the medical technology company’s stock worth $2,421,000 after acquiring an additional 626 shares during the last quarter. Retirement Systems of Alabama lifted its holdings in Stryker Corporation by 2.5% during the 3rd quarter. Retirement Systems of Alabama now owns 234,870 shares of the medical technology company’s stock worth $33,356,000 after buying an additional 5,656 shares during the period. Lockheed Martin Investment Management Co. acquired a new position in Stryker Corporation during the 2nd quarter worth about $1,249,000. Toronto Dominion Bank lifted its holdings in Stryker Corporation by 25.8% during the 2nd quarter. Toronto Dominion Bank now owns 105,403 shares of the medical technology company’s stock worth $14,625,000 after buying an additional 21,585 shares during the period. Finally, Colonial Trust Advisors lifted its holdings in Stryker Corporation by 56.1% during the 2nd quarter. Colonial Trust Advisors now owns 23,446 shares of the medical technology company’s stock worth $3,254,000 after buying an additional 8,426 shares during the period. Institutional investors own 74.15% of the company’s stock.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Analyst Recommendations for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply